DrugPatentWatch Database Preview
Details for Patent: 10,052,267
Which drugs does patent 10,052,267 protect, and when does it expire?
Patent 10,052,267 protects QBREXZA and is included in one NDA.
This patent has eight patent family members in six countries.
Summary for Patent: 10,052,267
| Title: | Topical glycopyrrolate formulations |
| Abstract: | Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer. |
| Inventor(s): | Johnston; Michael (Yarraville, AU), Houlden; Robert James (Kilsyth, AU) |
| Assignee: | ROSE U, LLC (Palo Alto, CA) |
| Application Number: | 15/662,166 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,052,267
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermira Inc | QBREXZA | glycopyrronium tosylate | CLOTH;TOPICAL | 210361-001 | Jun 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | TOPICAL TREATMENT OF PRIMARY AXILLARY HYPERHIDROSIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,052,267
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008314628 | Start Trial | |||
| Australia | 2014203072 | Start Trial | |||
| Canada | 2702830 | Start Trial | |||
| European Patent Office | 2200550 | Start Trial | |||
| European Patent Office | 3415127 | Start Trial | |||
| Spain | 2671874 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
